Layilin, a talin-binding hyaluronan receptor, is expressed in human articular chondrocytes and synoviocytes and is down-regulated by interleukin-1β

REFERENCES

• Borowsky ML, Hynes RO. Layilin, a novel talin-binding trans-membrane protein homologous with C-type lectins, is localized in membrane ruffles. J Cell Biol. 1998;143(2):429–42.
   PubMed Web of Science ®Google Scholar
• Bono P, Cordero E, Johnson K, Borowsky M, Ramesh V, Jacks T, et al. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin. Exp Cell Res. 2005;308(1):177–87.
   PubMed Web of Science ®Google Scholar
• Bono P, Rubin K, Higgins JM, Hynes RO. Layilin, a novel integral membrane protein, is a hyaluronan receptor. Mol Biol Cell. 2001;12(4):891–900.
   PubMed Web of Science ®Google Scholar
• Yatabe T, Mochizuki S, Takizawa M, Chijiiwa M, Okada A, Kimura T, et al. Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes. Ann Rheum Dis. 2009;68(6):1051–8.
   PubMed Web of Science ®Google Scholar
• Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. High molec-ular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteo-arthr Cartil. 2006;14(12):1237–47.
   Google Scholar
• Hashizume M, Mihara M. Desirable effect of combination ther-apy with high molecular weight hyaluronate and NSAIDs on MMP production. Osteoarthr Cartil. 2009;17(11):1513–8.
   PubMed Web of Science ®Google Scholar
• Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT. Efficacy and safety of intraarticular sodium hyaluro-nate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res. 2001;385:130–43.
   PubMed Web of Science ®Google Scholar
• Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. HyaluronanMulti-centre Trial Group. Ann Rheum Dis. 1996;55(7):424–31.
   PubMed Web of Science ®Google Scholar
• Roth A, Mollenhauer J, Wagner A, Fuhrmann R, Straub A, Venbrocks RA, et al. Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflamma-tion and destruction in rat antigen-induced arthritis. Arthritis Res Ther. 2005;7(3):R677–86.
   PubMed Web of Science ®Google Scholar
• Lisignoli G, Grassi F, Piacentini A, Cocchini B, Remiddi G, Bevilacqua C, et al. Hyaluronan does not affect cytokine andchemokine expression in osteoarthritic chondrocytes and syno-viocytes. Osteoarthr Cartil. 2001;9(2):161–8.
   PubMed Web of Science ®Google Scholar
• Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005;11(11):1173–9.
   PubMed Web of Science ®Google Scholar
• Naor D, Nedvetzki S. CD44 in rheumatoid arthritis. Arthritis Res Ther. 2003;5(3):105–15.
   PubMed Web of Science ®Google Scholar
• Goodison S, Urquidi V, Tarin D. CD44 cell adhesion molecules. Mol Pathol. 1999;52(4):189–96.
   Google Scholar
• Tanaka M, Masuko-Hongo K, Kato T, Nishioka K, Nakamura H. Suppressive effects of hyaluronan on MMP-1 and RANTES production from chondrocytes. Rheumatol Int. 2006;26(3): 185–90.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Goomer RS, Harwood F, Kubo T, Hirasawa Y, Arnie' D. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin- lbeta (IL- lbeta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthr Cartil. 1999;7(2): 182–90.
   Google Scholar
• Qiu B, Liu SQ, Peng H, Wang HB. The effects of sodium hyaluronate on mRNA expressions of matrix metalloproteinase-1, -3 and tissue inhibitor of metalloproteinase-1 in cartilage and synovium of traumatic osteoarthritis model. Chin J Traumatol. 2005;8(1):8–12.
   PubMedGoogle Scholar
• Nishida Y, D'Souza AL, Thonar EJ, Knudson W. Stimulation of hyaluronan metabolism by interleukin-1alpha in human articular cartilage. Arthritis Rheum. 2000;43(6):1315–26.
   PubMed Web of Science ®Google Scholar
• Culty M, Nguyen HA, Underhill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol. 1992;116(4):1055–62.
   Google Scholar
• Chin JE, Winterrowd GE, Krzesicki RF, Sanders ME. Role of cytokines in inflammatory synovitis. The coordinate regulation of intercellular adhesion molecule 1 and HLA class I and class II antigens in rheumatoid synovial fibroblasts. Arthritis Rheum. 1990;33(12) : 1776–86.
   Google Scholar
• Shimizu M, Yasuda T, Nakagawa T, Yamashita E, Julovi SM, Hiramitsu T, et al. Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines. J Rheumatol. 2003;30(6):1164–72.
   PubMed Web of Science ®Google Scholar
• Cillero-Pastor B, Ruiz-Romero C, Carames B, Lopez-Armada MJ, Blanco FJ. Proteomic analysis by two-dimensional electro-phoresis to identify the normal human chondrocyte proteome stimulated by tumor necrosis factor alpha and interleukin- lbeta. Arthritis Rheum. 2010;62(3):802–14.
   PubMed Web of Science ®Google Scholar
• Moldovan F, Pelletier JP, Hambor J, Cloutier JM, Martel-Pelle-tier J. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta. Arthritis Rheum. 1997;40(9):1653–61.
   Google Scholar
• Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 2002;4(3):157–64.
   PubMedGoogle Scholar
• Anandacoomarasamy A, Bagga H, Ding C, Burkhardt D, Sam-brook PN, March LM. Predictors of clinical response to intraar-ticular Hylan injections-a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging. J Rheumatol. 2008;35(4):685–90.
   Google Scholar
• Julovi SM, Ito H, Nishitani K, Jackson CJ, Nakamura T. Hya-luronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38. J Orthop Res. 2011;29(2): 258–64.
   Google Scholar
• Julovi SM, Yasuda T, Shimizu M, Hiramitsu T, Nakamura T. Inhibition of interleukin- lbeta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage. Arthritis Rheum. 2004;50(2):516–25.
   Google Scholar
• Wegener KL, Basran J, Bagshaw CR, Campbell ID, Roberts GC, Critchley DR, et al. Structural basis for the interaction between the cytoplasmic domain of the hyaluronate receptor layilin and the talin F3 subdomain. J Mol Biol. 2008;382(1):112–26.
   PubMed Web of Science ®Google Scholar
• Rovillain E, Mansfield L, Lord CJ, Ashworth A, Jat PS. An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senes-cence. BMC Genomics. 2010;12: 355.
   Google Scholar